Table 5 The frequency of patients achieving different inter-injection intervals after receiving the third loading dose at week 8 in the two groups
Treatment | Interval of 4Â weeks from last injection | Interval of 8Â weeks from last injection | Interval of 12Â weeks from last injection | Interval of 16Â weeks from last injection | Interval of 20Â weeks from last injection | Interval of 24Â weeks from last injection | Interval of 28Â weeks from last injection | Interval of 32Â weeks from last injection | Interval of 36Â weeks from last injection | NO injection after week 8 |
|---|---|---|---|---|---|---|---|---|---|---|
Brolucizumab (94 injections after week 8) | 16 | 7 | 18 | 23 | 13 | 11 | 4 | 1 | 1 | 5 |
Aflibercept(180 injections after week 8) | 79 | 39 | 37 | 13 | 9 | 2 | 1 | 0 | 0 | 1 |